MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 11, 2005; DOI: 10.1124/mol.105.015750


0026-895X/05/6805-1271-1280$20.00
Mol Pharmacol 68:1271-1280, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015750v1
68/5/1271    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tunaru, S.
Right arrow Articles by Offermanns, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tunaru, S.
Right arrow Articles by Offermanns, S.

Characterization of Determinants of Ligand Binding to the Nicotinic Acid Receptor GPR109A (HM74A/PUMA-G)

Sorin Tunaru, Jens Lättig, Jukka Kero, Gerd Krause, and Stefan Offermanns

Institute of Pharmacology, University of Heidelberg, Heidelberg, Germany (S.T., J.K., S.O.); and Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany (J.L., G.K.)

The G-protein-coupled receptor GPR109A (HM74A/PUMA-G) has recently been shown to function as a receptor for nicotinic acid (niacin) and to mediate its antilipolytic effects. Nicotinic acid is able to strongly raise plasma levels of high-density lipoprotein cholesterol, a property that distinguishes nicotinic acid from other lipid-lowering drugs. To investigate the structural determinants of GPR109A ligand binding, we performed site-directed mutagenesis of putative ligand binding residues combined with generation of chimeric receptors consisting of GPR109A and its close relative GPR109B, which does not bind nicotinic acid. We could identify Asn86/Trp91 [transmembrane helix (TMH) 2/extracellular loop (ECL) 1], Arg111 (TMH3), Ser178 (ECL2), Phe276 (TMH7), and Tyr284 (TMH7) as amino acid residues critical for binding of nicotinic acid. Together with data from molecular modeling studies, our data suggest that the ligand binding pocket for nicotinic acid of GPR109A is distinct from that of most other group A receptors. Although Arg111 at TMH3 serves as the basic anchor point for the carboxylate ligands, the ring system of nicotinic acid is embedded between Trp91 at the junction TMH2/ECL1 and Phe276/Tyr284 at TMH7. The heterocyclic ring is also bound to Ser178 at ECL2 via an H-bond. These data will facilitate the design of new antidyslipidemic drugs acting via GPR109A.


Received June 15, 2005; accepted August 10, 2005

Address correspondence to: Stefan Offermanns, Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. E-mail: stefan.offermanns{at}urz.uni-heidelberg.de




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. S. Torhan, B. Cheewatrakoolpong, L. Kwee, and S. Greenfeder
Cloning and characterization of the hamster and guinea pig nicotinic acid receptors
J. Lipid Res., September 1, 2007; 48(9): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Basu, V. R. Jala, S. Mathis, S. T. Rajagopal, A. Del Prete, P. Maturu, J. O. Trent, and B. Haribabu
Critical Role for Polar Residues in Coupling Leukotriene B4 Binding to Signal Transduction in BLT1
J. Biol. Chem., March 30, 2007; 282(13): 10005 - 10017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Krietsch, M. S. Fernandes, J. Kero, R. Losel, M. Heyens, E. W.-F. Lam, I. Huhtaniemi, J. J. Brosens, and B. Gellersen
Human Homologs of the Putative G Protein-Coupled Membrane Progestin Receptors (mPR{alpha}, {beta}, and {gamma}) Localize to the Endoplasmic Reticulum and Are Not Activated by Progesterone
Mol. Endocrinol., December 1, 2006; 20(12): 3146 - 3164.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jaschke, S. Neumann, S. Moore, C. J. Thomas, A.-O. Colson, S. Costanzi, G. Kleinau, J.-K. Jiang, R. Paschke, B. M. Raaka, et al.
A Low Molecular Weight Agonist Signals by Binding to the Transmembrane Domain of Thyroid-stimulating Hormone Receptor (TSHR) and Luteinizing Hormone/Chorionic Gonadotropin Receptor (LHCGR)
J. Biol. Chem., April 14, 2006; 281(15): 9841 - 9844.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics